{
    "Trade/Device Name(s)": [
        "CellaVision DC-1",
        "CellaVision DC-1 PPA"
    ],
    "Submitter Information": "CellaVision AB",
    "510(k) Number": "K200595",
    "Predicate Device Reference 510(k) Number(s)": [
        "K092868"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JOY"
    ],
    "Summary Letter Date": "October 16, 2020",
    "Summary Letter Received Date": "March 6, 2020",
    "Submission Date": "September 19, 2019",
    "Regulation Number(s)": [
        "21 CFR 864.5260"
    ],
    "Regulation Name(s)": [
        "Automated Cell-Locating Device"
    ],
    "Analyte Class(es)": [
        "hematology"
    ],
    "Analyte(s)": [
        "White blood cells",
        "Red blood cells",
        "Platelets"
    ],
    "Specimen Type(s)": [
        "Peripheral whole blood"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "K2EDTA tube",
        "K3EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "CellaVision DC-1"
    ],
    "Method(s)/Technology(ies)": [
        "Digital microscopy",
        "Convolutional Neural Network (CNN)",
        "Artificial intelligence image analysis"
    ],
    "Methodologies": [
        "Automated cell location",
        "Image-based cell classification",
        "Differential count",
        "RBC morphology characterization",
        "Platelet estimation"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Software",
        "Instrument",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for CellaVision DC-1 automated cell-locating analyzer using digital microscopy and AI for hematology analysis of peripheral blood smears",
    "Indications for Use Summary": "Intended for in vitro diagnostic use in clinical laboratories for differential count of white blood cells, characterization of red blood cell morphology, and platelet estimation from peripheral blood smears by trained operators.",
    "fda_folder": "Hematology"
}